BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30044162)

  • 21. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
    Song J; Shen H; Li J; Huang Z; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.
    Fraison E; Kostova E; Moran LJ; Bilal S; Ee CC; Venetis C; Costello MF
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD005552. PubMed ID: 32794179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of simvastatin plus metformin for polycystic ovary syndrome: A meta-analysis of randomized controlled trials.
    Meng J; Zhu Y
    Eur J Obstet Gynecol Reprod Biol; 2021 Feb; 257():19-24. PubMed ID: 33338947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment.
    Velija-Ašimi Z
    Bosn J Basic Med Sci; 2013 Aug; 13(3):180-5. PubMed ID: 23988170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome.
    Sönmez AS; Yasar L; Savan K; Koç S; Ozcan J; Toklar A; Yazicioğu F; Akgün A; Sut N
    Hum Reprod; 2005 Jan; 20(1):175-9. PubMed ID: 15513975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.
    Gambineri A; Pelusi C; Genghini S; Morselli-Labate AM; Cacciari M; Pagotto U; Pasquali R
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):241-9. PubMed ID: 14725687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
    Moghetti P; Castello R; Negri C; Tosi F; Perrone F; Caputo M; Zanolin E; Muggeo M
    J Clin Endocrinol Metab; 2000 Jan; 85(1):139-46. PubMed ID: 10634377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study.
    Kazerooni T; Shojaei-Baghini A; Dehbashi S; Asadi N; Ghaffarpasand F; Kazerooni Y
    Fertil Steril; 2010 Nov; 94(6):2208-13. PubMed ID: 20079899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome.
    Meenakumari KJ; Agarwal S; Krishna A; Pandey LK
    Braz J Med Biol Res; 2004 Nov; 37(11):1637-44. PubMed ID: 15517078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
    Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic Effect of Curcumin in Women with Polycystic Ovary Syndrome Receiving Metformin: A Randomized Controlled Trial.
    Sohrevardi SM; Heydari B; Azarpazhooh MR; Teymourzadeh M; Simental-Mendía LE; Atkin SL; Sahebkar A; Karimi-Zarchi M
    Adv Exp Med Biol; 2021; 1308():109-117. PubMed ID: 33861440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Sahin Y; Unluhizarci K; Yilmazsoy A; Yikilmaz A; Aygen E; Kelestimur F
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):904-8. PubMed ID: 17666089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.
    Kolodziejczyk B; Duleba AJ; Spaczynski RZ; Pawelczyk L
    Fertil Steril; 2000 Jun; 73(6):1149-54. PubMed ID: 10856473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acupuncture treatment for insulin sensitivity of women with polycystic ovary syndrome and insulin resistance: a study protocol for a randomized controlled trial.
    Li J; Ng EH; Stener-Victorin E; Hu Z; Shao X; Wang H; Li M; Lai M; Xie C; Su N; Yu C; Liu J; Wu T; Ma H
    Trials; 2017 Mar; 18(1):115. PubMed ID: 28274268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome.
    Sahin Y; Yirmibeş U; Keleştimur F; Aygen E
    Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):214-20. PubMed ID: 15063963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor alpha versus LH and androstendione as a reliable predictor of spontaneous ovulation after laparoscopic ovarian drilling for women with clomiphene citrate resistance polycystic ovarian disease.
    Seyam E; Hefzy E
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():126-133. PubMed ID: 29408743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome.
    Oner G; Muderris II
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):127-31. PubMed ID: 21831508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial.
    Yarali H; Yildiz BO; Demirol A; Zeyneloğlu HB; Yiğit N; Bükülmez O; Koray Z
    Hum Reprod; 2002 Feb; 17(2):289-94. PubMed ID: 11821265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
    Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
    Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.